Reporter - U.S. Pharmaceutical Industry, The Wall Street Journal - NY
The Wall Street Journal is looking for an enterprising newshound to cover the U.S. pharmaceutical industry.
Big Pharma is at the center of changing national policy, dealmaking and science, and the successful reporter must dominate national coverage of every aspect of this dynamic industry.
The ideal candidate will have a proven ability to break news and get inside companies to explain the workings of a complex industry, as well as the writing chops to bring stories to life with compelling narratives.
Experience covering drug makers is desirable, but not required. What is required is the drive to juggle breaking news with longer-term projects and work across platforms and teams.
We are looking for a reporter who can produce stories in all their forms, from the written word to podcasts, video and graphics. The job is based in New York in the Health & Science team.
Click 'Apply' now.
Dow Jones, Making Careers Newsworthy
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, protected veteran status, or disability status. EEO/AA/M/F/Disabled/Vets.
Dow Jones is committed to providing reasonable accommodation for qualified individuals with disabilities, in our job application and/or interview process. If you need assistance or accommodation in completing your application, due to a disability, please reach out to us at TalentResourceTeam@dowjones.com. Please put “Reasonable Accommodation" in the subject line.
The Wall Street Journal is a global news organization that provides leading news, information, commentary and analysis. The Wall Street Journal engages readers across print, digital, mobile, social, and video.
Building on its heritage as the preeminent source of global business and financial news, the Journal includes coverage of U.S. and world news, politics, arts, culture, lifestyle, sports, and health. It holds 36 Pulitzer Prizes for outstanding journalism.
The Wall Street Journal is published by Dow Jones, a division of News Corp (NASDAQ: NWS, NWSA; ASX: NWS, NWSLV).